Glioblastoma multiforme (GBM) is the most com- mon and aggressive cancer of the central nervous system. Despite prior advances in diagnosis and treatment, the prognosis for GBM patients remains poor. Novel therapies might help preserve neurological function and maintain patients’ independence, but could raise the risk of treatment- related side effects. These patients may have unique preferences for health outcomes.
Authors: J MacEwan, J Doctor, et al
Publication Year: 2016